Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  PaySign, Inc.    PAYS


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Paysign : Announces Leadership Appointments to Drive Patient Affordability Business Line

share with twitter share with LinkedIn share with facebook
06/01/2020 | 08:32am EDT

Paysign, Inc. (NASDAQ:PAYS), a vertically integrated provider of innovative prepaid card programs, digital banking, and processing services for corporate, consumer, and government applications, today announced three leadership appointments. Each appointee will be focused on enhancing Paysign’s Patient Affordability capabilities and will have a reporting relationship to Alberto Negron, Executive Vice President Channel Strategy.

Burke Williams has been appointed Senior Vice President of Business Development. In this role Williams will focus on expanding our HUB and Copay marketing client base. Williams will also focus on expanding our market reach to include non-profit organizations and foundations for their patient assistance programs. A proven industry veteran, Williams brings a wealth of experience to Paysign, having held a variety of roles at TrialCard, Inc. over a 15-year period, most recently as VP of Business Development, Patient Reimbursement and Engagement Strategy.

Matthew Turner has been named Vice President, Head of Patient Affordability Solutions. Turner is responsible for developing and managing Paysign’s Patient Affordability services. A ten year veteran of the healthcare and pharmaceutical services industry, Turner most recently served as Director of Product Management for TrialCard Inc, where he was responsible for risk mitigation, compliance, and pharmacy product lines.

Brett Squire has been appointed Senior Director, Client Services and Informatics. Squire has worked with brands across numerous therapeutic areas, both within the manufacturer and as a service vendor. Prior to working with Paysign, he worked for Fortovia Therapeutics as the Director of Business Analysis and Automation. Before joining Fortovia, Squire worked for TrialCard Inc. as the Director of Client Services where he supported his manufacturing clients with Hub Services and Patient Affordability Solutions.

“I am extremely pleased to welcome Burke, Matt and Brett to our Patient Affordability team,” said Mark Newcomer, Chief Executive Officer, Paysign. “They are all recognized industry leaders with demonstrated track records of success. Given their collective experience in patient affordability, we are well positioned to accelerate our growth in the space”.

With new opportunities opening in the space, Paysign has expanded beyond our long-standing pharmaceutical payment offerings and established a Patient Affordability business-line to include other services required by our HUB clients. These new services include: pharmacy-based co-pay, medical claims processing and payments, centralized billing, and payment services, as well as other products. To learn more, visit https://paysign.com/solutions/pharmaceutical-services/.

About Paysign, Inc.

Paysign, Inc (NASDAQ: PAYS) is an experienced and trusted prepaid debit card payment solutions provider as well as an integrated payment processor that has managed millions of prepaid debit cards in its portfolio. Paysign conceptualizes, develops and manages payment solutions, prepaid card programs, and customized payment services. Paysign’s corporate incentive prepaid cards are changing the way corporations reward, motivate, and engage their current and potential customers, employees, and agents. Paysign’s customizable solutions offer significant cost savings while improving brand recognition and customer loyalty. For over 15 years healthcare companies, major pharmaceutical companies, multinationals, prestigious universities, and social media companies have relied on Paysign to provide state of the art prepaid payment programs tailored to their unique requirements. Paysign is a registered trademark of Paysign, Inc. in the United States and other countries. For more information visit us at paysign.com, or follow us on Facebook, Twitter, and LinkedIn.

Forward-Looking Statements

Certain statements contained in this press release may be deemed to be forward-looking statements under federal securities laws, and the company intends that such forward-looking statements be subject to the safe-harbor created thereby. All statements, other than statements of fact, included in this release, are forward-looking statements. Such forward-looking statements include, among others, expanding long-standing pharmaceutical payment offerings and enhancing Patient Affordability capabilities. We caution that these statements are qualified by important risks, uncertainties, and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the inability to continue our current growth rate in future periods; identified material weaknesses in our internal control over financial reporting which could, if not remediated, adversely affect our ability to report our financial condition and results of operations in a timely and accurate manner; that a downturn in the economy, including as a result of COVID-19, could reduce our customer base and demand for our products and services, which could have an adverse effect on our business, financial condition, profitability, and cash flows; operating in a highly regulated environment; failure by us or business partners to comply with applicable laws and regulations; changes in the laws, regulations, credit card association rules or other industry standards affecting our business; that a data security breach could expose us to liability and protracted and costly litigation; and other risk factors set forth in our Form 10-K for the year ended December 31, 2019. Except to the extent required by federal securities laws, the company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.

© Business Wire 2020

share with twitter share with LinkedIn share with facebook
All news about PAYSIGN, INC.
08/14PAYSIGN : Management's discussion and analysis of financial condition and result..
08/13PAYSIGN, INC. : Results of Operations and Financial Condition, Financial Stateme..
08/13PAYSIGN, INC. : Reports Second Quarter 2020 Financial Results
08/07PAYSIGN, INC. : to Host 2nd Quarter Earnings Call
08/07PAYSIGN, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (for..
07/02PAYSIGN, INC. : Changes in Registrant's Certifying Accountant, Financial Stateme..
06/01PAYSIGN : Announces Leadership Appointments to Drive Patient Affordability Busin..
05/17PAYS UPCOMING DEADLINE : Bronstein, Gewirtz & Grossman, LLC Reminds Paysign, Inc..
05/15THE LAW OFFICES OF FRANK R. CRUZ : Reminds Investors of Looming Deadline in the ..
More news
Financials (USD)
Sales 2020 34,2 M - -
Net income 2020 2,70 M - -
Net Debt 2020 - - -
P/E ratio 2020 116x
Yield 2020 -
Capitalization 272 M 272 M -
Capi. / Sales 2020 7,96x
Capi. / Sales 2021 4,52x
Nbr of Employees 70
Free-Float 61,4%
Duration : Period :
PaySign, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PAYSIGN, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 10,19 $
Last Close Price 5,52 $
Spread / Highest target 99,3%
Spread / Average Target 84,6%
Spread / Lowest Target 58,5%
EPS Revisions
Mark R. Newcomer Vice Chairman, President & Chief Executive Officer
Daniel R. Henry Chairman
Joan M. Herman Chief Operating Officer & Director
Mark K. Attinger Chief Financial Officer
Daniel H. Spence Director & Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
PAYSIGN, INC.-45.62%272
SQUARE, INC.182.56%78 403
FISERV, INC.-12.50%67 755